Literature DB >> 7432553

Effect of non-catecholic 2-aminotetralin derivatives on dopamine metabolism in the rat striatum.

M G Feenstra, H Rollema, D Dijkstra, C J Grol, A S Horn, B H Westerink.   

Abstract

The concentrations of dopamine (DA), dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were measured in the striatum of rats after i.p. injection of dipropyl-2-aminotetralin and the four positional isomers of monohydroxy-dipropyl-2-aminotetralin. All compounds except 8-OH dipropylaminotetralin caused a decrease in DOPAC- and HVA-concentrations. In addition, 5-OH-dipropylaminotetralin produced a small elevation in DA concentrations. In contrast, 7-OH dipropylaminotetralin, in doses of 100 mumol/kg and more, decreased DA to 50% and initially increased HVA and DOPAC to about 200%, after which the concentrations of the metabolites fell to 30% or less. The 5-OH isomer was found to be the most potent compound, decreasing HVA concentrations to 70% at a dose of 0.14 mumol/kg. The potencies are compared to those of catechol-group containing DA-agonists such as apomorphine and N,N-dipropyl-5,6-dihydroxy-2-aminotetralin. In addition, a comparison is made with reported behavioural data. It is suggested that the more active N-alkylated 2-aminotetralins have a conformation which corresponds to that of the alpha rotamer of dopamine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7432553     DOI: 10.1007/bf00505736

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  22 in total

1.  Correlation between neuroleptic-induced suppression of stereotyped behaviour and HVA concentrations in rat brain.

Authors:  H Rollema; B H Westerink; C J Grol
Journal:  J Pharm Pharmacol       Date:  1976-04       Impact factor: 3.765

2.  Conformational analysis of dopamine by the INDO molecular orbital method.

Authors:  C J Grol; H Rollema
Journal:  J Pharm Pharmacol       Date:  1977-03       Impact factor: 3.765

3.  Synthesis and pharmacology of some 2-aminotetralins. Dopamine receptor agonists.

Authors:  J D McDermed; G M McKenzie; A P Phillips
Journal:  J Med Chem       Date:  1975-04       Impact factor: 7.446

4.  Dopamine receptors and cyclic AMP in rabbit retina: a pharmacological and stereochemical analysis using semi-rigid analogs of dopamine (aminotetralins) and thioxanthene isomers.

Authors:  M Schorderet; J McDermed; P Magistretti
Journal:  J Physiol (Paris)       Date:  1978

5.  Aporphines. 11. Synthesis and dopaminergic acitivity of monohydroxyaporphines. Total synthesis of (plus, minus)-11-hydroxyaporphine, (plus and minus)-11-hydroxynoraporphine, and (plus, minus)-11-hydroxy-N-n-propylnoraporphine.

Authors:  J L Neumeyer; F E Granchelli
Journal:  J Med Chem       Date:  1974-10       Impact factor: 7.446

6.  Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum.

Authors:  J G Cannon; B Costall; P M Laduron; J E Leysen; R J Naylor
Journal:  Biochem Pharmacol       Date:  1978-05-15       Impact factor: 5.858

7.  The effect of 2-substitution on conformations and brain concentrations of phenothiazine-neuroleptics in relation to dopamine-antagonism.

Authors:  C J Grol; H Rollema; H W Asselbergs
Journal:  J Pharm Pharmacol       Date:  1979-10       Impact factor: 3.765

8.  Effect of dihydroxy-2-aminotetralin derivatives on dopamine metabolism in the rat striatum.

Authors:  M G Feenstra; H Rollema; A S Horn; D Dijkstra; C J Grol; B H Westerink; A Westerbrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-01       Impact factor: 3.000

9.  Rapid concurrent automated fluorimetric assay of noradrenaline, dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 3-methoxytyramine in milligram amounts of nervous tissue after isolation on Sephadex G10.

Authors:  B H Westerink; J Korf
Journal:  J Neurochem       Date:  1977-10       Impact factor: 5.372

10.  Preparation and biological actions of some symmetrically N,N-disubstituted dopamines.

Authors:  J G Cannon; F L Hsu; J P Long; J R Flynn; B Costall; R J Naylor
Journal:  J Med Chem       Date:  1978-03       Impact factor: 7.446

View more
  5 in total

1.  Radioreceptor binding reveals the potencies of N,N-disubstituted 2-aminotetralins as D2 dopamine agonists.

Authors:  P M Beart; C J Cook; M Cincotta; D J de Vries; P Tepper; D Dijkstra; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

2.  5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus.

Authors:  R Markstein; D Hoyer; G Engel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

3.  A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity.

Authors:  M G Feenstra; C Sumners; J H Goedemoed; J B de Vries; H Rollema; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

4.  S(-)DP-5,6-ADTN as an in vivo dopamine receptor ligand: relation between displacement by dopamine agonists and their pharmacological effects.

Authors:  H Rollema; M G Feenstra; C J Grol; M H Lewis; L Staples; R B Mailman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

5.  The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.

Authors:  J C van Oene; J B de Vries; A S Horn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.